drugset

drugset / Trial / NCT00273039

A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

NCT00273039 ↗

Phase 2 Completed 242 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in subjects with Social Anxiety Disorder

Timeline

Start: 2005-08
Primary completion: 2006-09
Completion: 2006-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Paroxetine	Small molecule	—	—

Indications